VolitionRx Limited Employee Benefits and Share-based Compensation
VolitionRx Limited (VNRX) reported Employee Benefits and Share-based Compensation of $1.27 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Notes › Compensation Related Costs
us-gaap:EmployeeBenefitsAndShareBasedCompensation · last filed 2025-03-31
- VolitionRx Limited employee benefits and share-based compensation for the quarter ending 2024-12-31 was $325.74K, a 30.06% decline year-over-year.
- VolitionRx Limited employee benefits and share-based compensation for the quarter ending 2023-12-31 was $465.73K.
- VolitionRx Limited employee benefits and share-based compensation for fiscal 2024 was $1.27M, a 44.59% decline from fiscal 2023.
- VolitionRx Limited employee benefits and share-based compensation for fiscal 2023 was $2.29M.
| Period end | Employee Benefits and Share-based Compensation 3 month | Employee Benefits and Share-based Compensation 9 month | Employee Benefits and Share-based Compensation 12 month |
|---|---|---|---|
| 2024-12-31 | $325.74K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.27M 10-K · filed 2025-03-31 | |
| 2024-09-30 | $942.80K 10-Q · filed 2024-11-14 | ||
| 2023-12-31 | $465.73K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $2.29M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $1.82M 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |